মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

harris pharmaceutical, inc. - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - terbinafine 250 mg - terbinafine tablets, usp are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (koh) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis. terbinafine tablets, usp are contraindicated in individuals with a history of allergic reaction to oral terbinafine because of the risk of anaphylaxis. pregnancy category b there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response and because treatment of onychomycosis can be postponed until after pregnancy is completed, it is recommended that terbinafine tablets not be initiated during pregnancy. oral reproduction studies have been performed in rabbits and rats at doses up to 300 mg/kg/day [12x to 23x the maximum recommended human dose (mrhd), in rabbits and rats, respe

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - terbinafine hydrochloride, quantity: 281.3 mg (equivalent: terbinafine, qty 250 mg) - tablet, uncoated - excipient ingredients: methylcellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - apo-terbinafine is indicated for: treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infections caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.

গ্রীস্ - গ্রিক - Εθνικός Οργανισμός Φαρμάκων

ΤΑΡΓΚΕΤ ΦΑΡΜΑ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Δ.Τ. target pharma ΜΟΝΟΠΡΟΣΩΠΗ ΕΠΕ Μενάνδρου 54,, 104 31 104 31, Αθήνα 210.5224830 - terbinafine hydrochloride - cream (ΚΡΕΜΑ) - 1% (w/w) - terbinafine hydrochloride 10mg - terbinafine

গ্রীস্ - গ্রিক - Εθνικός Οργανισμός Φαρμάκων

ΤΑΡΓΚΕΤ ΦΑΡΜΑ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Δ.Τ. target pharma ΜΟΝΟΠΡΟΣΩΠΗ ΕΠΕ Μενάνδρου 54,, 104 31 104 31, Αθήνα 210.5224830 - terbinafine hydrochloride - spr.sol (ΔΕΡΜΑΤΙΚΟ ΕΚΝΕΦΩΜΑ, ΔΙΑΛΥΜΑ) - 1% (w/v) - terbinafine hydrochloride 10mg - terbinafine

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - terbinafine hydrochloride - oral tablet - 250mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

relonchem ltd - terbinafine hydrochloride - oral tablet - 250mg

বেলজিয়াম - ডাচ - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - terbinafinehydrochloride 281,3 mg - eq. terbinafine 250 mg - tablet - 250 mg - terbinafinehydrochloride 281.3 mg - terbinafine

বেলজিয়াম - ডাচ - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex europe b.v. - terbinafinehydrochloride 281,3 mg - eq. terbinafine 250 mg - tablet - 250 mg - terbinafinehydrochloride 281.3 mg - terbinafine

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - terbinafine hydrochloride - oral tablet - 250mg

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

a-s medication solutions - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (koh) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis. terbinafine tablets are contraindicated in patients with: - chronic or active liver disease [see warnings and precautions (5.1)] - history of allergic reaction to oral terbinafine because of the risk of anaphylaxis [see adverse reactions (6.2)] risk summary available data from postmarketing cases on the use of terbinafine tablets in pregnant women are insufficient to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, terbinafine did not cause malformations or any harm to the fetus when administered to pregnant rabbits and rats during the period of organogenesis at oral do